Life Sciences Tools and Services
Company Overview of Rubicon Genomics, Inc.
Rubicon Genomics, Inc. engages in the development and commercialization of sample-specific nucleic acid library preparation products for use in research and clinical testing on next-generation sequencing (NGS), microarray, and q-PCR platforms. The company creates molecular biology tools for genetic, epigenetic, and expression analysis of various samples to facilitate gene-based research, drug development, and diagnostics. Its products include ThruPLEX DNA-seq kits to generate DNA libraries with expanded multiplexing capability and diversity with lower duplication rates; PicoPLEX DNA-seq kits to streamline library preparation and PicoPLEX process used by IVF clinics for pre-implantation genet...
4743 Venture Drive
Ann Arbor, MI 48108
Founded in 2000
Key Executives for Rubicon Genomics, Inc.
Chairman, Chief Executive Officer and President
Co-Founder and Chief Scientific Officer
Vice President of Business Development
Compensation as of Fiscal Year 2016.
Rubicon Genomics, Inc. Key Developments
Rubicon Genomics, Inc. Provides Sales Guidance for 2016
Apr 12 16
Rubicon Genomics, Inc. provided sales guidance for 2016. The company expects to post sales gains of greater than 40% in 2016.
Rubicon Genomics, Inc Announces Distribution Agreement with Beckman Coulter Life Sciences for its ThruPLEX Plasma-Seq Kits
Feb 8 16
Rubicon Genomics, Inc. announced a new agreement with Beckman Coulter Life Sciences for distribution of its ThruPLEX Plasmaseq kits for research applications. ThruPLEX Plasmaseq prepares DNA nextgeneration sequencing (NGS) libraries for the analysis of cellfree DNA circulating in plasma. The nonexclusive agreement covers the U.S. and Canada. It follows an announcement last fall that the ThruPLEX Plasmaseq kit has been automated for use with Beckman Coulter's Biomek FXP Automated Workstation, a leading automated liquid handling solution for laboratories worldwide. ThruPLEX Plasmaseq kits enable liquid biopsies for research applications in cancer and other conditions by producing highly reproducible libraries for Illumina instruments from small amounts of cellfree DNA in plasma (from less than 1 ng up to 30 ng of cell free DNA.) Its optimized repair and ligation chemistries and a modified protocol provide high library diversity at low input amounts with broad and consistent GC coverage. ThruPLEX Plasmaseq libraries are suitable for whole genome, whole exome and targeted gene sequencing. The performance of the ThruPLEX Plasmaseq kit has been validated by researchers at the Karolinska Institute in Sweden and Cancer Research UK (CRUK) in Cambridge, UK.
Rubicon Genomics, Inc. Adds Delonix Healthcare Pvt. Ltd and Biocena Ltd. as New Distributors
Jan 11 16
Rubicon Genomics, Inc. announced the addition of new distributors in India and Poland. The new distributors are Delonix Healthcare Pvt. Ltd. and Biocena Ltd.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries